Free Trial

vTv Therapeutics (VTVT) SEC Filings & 10K Form

vTv Therapeutics logo
$21.31 +1.36 (+6.82%)
Closing price 05/1/2025 03:58 PM Eastern
Extended Trading
$21.31 0.00 (0.00%)
As of 04:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent vTv Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2025
3:40 PM
AKKARAJU SRINIVAS (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:27 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
3:28 PM
vTv Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/17/2025
8:03 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:14 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:33 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:15 PM
AKKARAJU SRINIVAS (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:15 PM
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:40 AM
FMR LLC (Filed by)
vTv Therapeutics (Subject)
Form SC 13G
10/25/2024
3:29 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:28 PM
vTv Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:27 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:17 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:41 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:39 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:40 PM
SPIEGELMAN DANIEL K (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:37 PM
Phillips Anne M. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:38 PM
Al-Marzooqi Fahed (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:22 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:22 PM
AKKARAJU SRINIVAS (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:37 PM
Phillips Anne M. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:38 PM
Tuch Steven L. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:40 PM
SEKHRI PAUL J (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:42 PM
Al-Marzooqi Fahed (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VTVT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners